Motivated, Engaged, and Organized: The New Molecular Cohorts of Lung Cancer
By D.R. Camidge Posted: June 2018 Just as physicians and scientists no longer treat lung cancer as a single disease because of molecular distinctions, patient advocacy groups also are becoming […] Read more
By Rachel Rosenthal, PhD, MSc, andCharles Swanton, FRCP, BSc, PhD Posted: June 2018 An evolving tumor and the immune system continuously adapt to each other. As a tumor develops increasing […] Read more
By Shani Shilo, DMD, PhD, andNir Peled, MD, PhD, FCCP Posted: June 2018 On March 6, 2018, the Israeli parliament, the Knesset, held a Science and Technology Committee meeting devoted […] Read more
By Gregory J. Riely, MD Posted: June 2018 The changes seen in the 2018 update of the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for […] Read more
Fabrice Barlesi, MD
Posted: June 2018 The 2018 Heine H. Hansen Award recipient was IASLC Lung Cancer News Associate Editor Fabrice Barlesi, MD. The award was presented at the 2018 European Lung Cancer […] Read more
Frances Shepherd, MD
Posted: June 2018 IASLC past-president Frances Shepherd, MD, has been awarded the 2018 Canada Gairdner Wightman Award for outstanding career leadership in medicine and medical science. Dr. Shepherd is a […] Read more
Pasi A. Janne, MD, PhD
Posted: June 2018 Pasi A. Janne, MD, PhD, was awarded the Second AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research. The award is given to […] Read more
Primo N. Lara, Jr., MD
Posted: June 2018 Primo N. Lara, Jr., MD, has been named director of the National Cancer Institute–designated UC Davis Comprehensive Cancer Center, leading a team of more than 300 scientists […] Read more
The Long Road Home
Figure. Prevalance of Water Pipe Usage Is Virtually at Epidemic Proportion in Parts of the Middle East Sources: Vardavas C, Filippidis F, Agaku I. http://tobaccocontrol.bmj.com. Accessed April 11, 2018. McKelvey […] Read more
Highlights from the IASLC 18th Lung Cancer Targeted Therapies Meeting keynote address. By Suresh S. Ramalingam, MD Posted: June 2018 EGFR-targeted therapy has entered a new phase as the result […] Read more